Advanced Therapy Medicinal Products: why patient engagement is even more important than in “traditional” therapies
While patient engagement from early development through market access to patient access is becoming more and more a standard in the pharmaceutical industry, it is even more important in cell-, gene, and organ replacement therapies (so-called ATMPs).